Home » Topics » BioWorld Science

BioWorld Science
RSS

Antibody-based therapeutics alliance formed by CAT and Icos

Dec. 22, 1997

Gensia pursues formation of Metabasis as separate company and announces Sankyo investment

Dec. 22, 1997

Isolation, structural elucidation and preliminary biological evaluation of new XOD inhibitor

Dec. 22, 1997

Novel nicotinic ligand discovered by British university researchers

Dec. 22, 1997

New antiviral agent for flu disclosed in patent literature

Dec. 22, 1997

Pharmacological characterization of LY-344864, a selective 5-HT1F receptor agonist

Dec. 22, 1997

HGS discloses new cysteine protease inhibitor

Dec. 22, 1997

In vitro and in vivo immunosuppressive effects of FTY-720

Dec. 22, 1997

Peptidomimetic inhibitors of protein farnesyltransferase from Merck & Co.

Dec. 22, 1997

Prevention of neurodegeneration in Parkinson's disease reported

Dec. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...